<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The best treatment for <z:hpo ids='HP_0003774'>end stage renal disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>) patients is kidney transplantation, but the renal transplant recipients still have a higher incidence of cardiovascular events compared with general population </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">Cardiovascular risk factors</z:e> were imposed long before <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>, as the majority of patients starting dialysis or kidney transplantation already have signs of advanced <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Artery calcification is an organized, regulated process similar to bone formation </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001717'>Coronary artery calcification</z:hpo> (CAC) is found frequently in advanced <z:mp ids='MP_0005338'>atherosclerotic lesions</z:mp> and could be a useful marker of them </plain></SENT>
<SENT sid="4" pm="."><plain>We evaluated the prevalence of CAC in 49 stable renal transplant recipients and in 48 age- and gender-matched patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) in stages 2-5 not requiring dialysis to assess risk factors associated with CAC </plain></SENT>
<SENT sid="5" pm="."><plain>Computed tomography was used for CAC detection and quantification (CAC score) </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of CAC was 43.8% in transplant recipients and 16.7% in CKD patients (p &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Transplant recipients with CAC were significantly older and had longer duration of CKD and/or dialysis than recipients without CAC </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, the serum levels of fetuin A (an inhibitor of <z:hpo ids='HP_0004934'>vascular calcification</z:hpo>) and albumin were significantly lower in CKD patients with CAC than those without CAC </plain></SENT>
<SENT sid="9" pm="."><plain>During the observation period (30 months), 30 patients, including 23 CKD patients, began dialysis, and 4 transplant recipients and 2 CKD patients died </plain></SENT>
<SENT sid="10" pm="."><plain>Independent predictors of mortality were age, serum amyloid A and the CAC score </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, the examination and prevention of risk factors associated with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> should be started at the beginning of <z:hpo ids='HP_0000083'>renal failure</z:hpo> </plain></SENT>
</text></document>